These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 8100361
21. Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire. Mukadi Y, Perriëns JH, St Louis ME, Brown C, Prignot J, Willame JC, Pouthier F, Kaboto M, Ryder RW, Portaels F. Lancet; 1993 Jul 17; 342(8864):143-6. PubMed ID: 8101257 [Abstract] [Full Text] [Related]
22. Impaired T-lymphocyte-dependent immune responses to microbial antigens in patients with HIV-1-associated persistent generalized lymphadenopathy. Ballet JJ, Couderc LJ, Rabian-Herzog C, Duval-Roy C, Janier M, Danon F, Clauvel JP, Seligmann M. AIDS; 1988 Aug 17; 2(4):291-7. PubMed ID: 2902865 [Abstract] [Full Text] [Related]
23. Correlation between CD4+ lymphocyte counts, concurrent antigen skin test and tuberculin skin test reactivity in human immunodeficiency virus type 1-infected and -uninfected children with tuberculosis. Madhi SA, Gray GE, Huebner RE, Sherman G, McKinnon D, Pettifor JM. Pediatr Infect Dis J; 1999 Sep 17; 18(9):800-5. PubMed ID: 10493341 [Abstract] [Full Text] [Related]
24. Direct visualization of cytokine-producing recall antigen-specific CD4 memory T cells in healthy individuals and HIV patients. Helms T, Boehm BO, Asaad RJ, Trezza RP, Lehmann PV, Tary-Lehmann M. J Immunol; 2000 Apr 01; 164(7):3723-32. PubMed ID: 10725731 [Abstract] [Full Text] [Related]
25. [Clinical usefulness of Multitest in the evaluation of cellular immunity]. Feijoó RM, Ardiles A, Lemp P, King A, Villamán JJ, Parra A, Silva M. Rev Med Chil; 1996 Mar 01; 124(3):327-36. PubMed ID: 9008945 [Abstract] [Full Text] [Related]
26. Delayed-type hypersensitivity in palmoplantar pustulosis: effect of cyclosporin A treatment on skin testing with recall antigens. Remitz A, Lauerma AI, Erkko P, Reitamo S. Acta Derm Venereol; 1996 Jul 01; 76(4):310-3. PubMed ID: 8869692 [Abstract] [Full Text] [Related]
27. Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group. Valdez H, Smith KY, Landay A, Connick E, Kuritzkes DR, Kessler H, Fox L, Spritzler J, Roe J, Lederman MB, Lederman HM, Evans TG, Heath-Chiozzi M, Lederman MM. AIDS; 2000 Jan 07; 14(1):11-21. PubMed ID: 10714563 [Abstract] [Full Text] [Related]
28. Relationship between cutaneous delayed hypersensitivity and cell-mediated immunity in vitro responses assessed by diphtheria and tetanus toxoids. Galant SP, Flod N, Shimizu I, Granger GA, Groncy CE. J Allergy Clin Immunol; 1977 Oct 07; 60(4):247-53. PubMed ID: 332750 [No Abstract] [Full Text] [Related]
29. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Caiaffa WT, Graham NM, Galai N, Rizzo RT, Nelson KE, Vlahov D. Arch Intern Med; 1995 Oct 23; 155(19):2111-7. PubMed ID: 7575072 [Abstract] [Full Text] [Related]
30. Prognostic value of proliferative responses to HIV-1 antigen in chronically HIV-infected patients under antiretroviral therapy. Mohm JM, Rump JA, Schulte-Mönting J, Schneider J. J Clin Virol; 2004 Jul 23; 30(3):239-42. PubMed ID: 15135742 [Abstract] [Full Text] [Related]
31. Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case. Saikh KU, Sesno J, Brandler P, Ulrich RG. Vaccine; 1998 Jul 23; 16(9-10):1029-38. PubMed ID: 9682355 [Abstract] [Full Text] [Related]
32. Delayed cutaneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell-mediated immunity. Gordon EH, Krouse HA, Kinney JL, Stiehm ER, Klaustermeyer WB. J Allergy Clin Immunol; 1983 Nov 23; 72(5 Pt 1):487-94. PubMed ID: 6355249 [Abstract] [Full Text] [Related]
33. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients. Diagbouga S, Fumoux F, Ledru E, Sanou PT, Barro D, Marchal G. Int J Tuberc Lung Dis; 1998 Apr 23; 2(4):317-23. PubMed ID: 9559403 [Abstract] [Full Text] [Related]
34. Human immunodeficiency virus status and delayed-type hypersensitivity skin testing in Ugandan children. Mandalakas AM, Guay L, Musoke P, Carroll-Pankhurst C, Olness KN. Pediatrics; 1999 Feb 23; 103(2):E21. PubMed ID: 9925867 [Abstract] [Full Text] [Related]
35. Impaired T-cell priming and proliferation in cats infected with feline immunodeficiency virus. Bishop SA, Williams NA, Gruffydd-Jones TJ, Harbour DA, Stokes CR. AIDS; 1992 Mar 23; 6(3):287-93. PubMed ID: 1348945 [Abstract] [Full Text] [Related]
36. Monitoring cellular immune function in HIV infection by the delayed hypersensitivity skin test: alternative to the CD4 T-cell count? Shearer WT. J Allergy Clin Immunol; 1999 Jan 23; 103(1 Pt 1):26-8. PubMed ID: 9893180 [No Abstract] [Full Text] [Related]
37. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs. Kawahara M, Matsuo K, Honda M. Clin Immunol; 2006 Apr 23; 119(1):67-78. PubMed ID: 16386958 [Abstract] [Full Text] [Related]
38. Requirement of the T cell receptor for antigen presentation by T lymphocytes. Effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells. Chirmule N, Kalyanaraman VS, Slade H, Oyaizu N, Pahwa S. Clin Exp Immunol; 1990 May 23; 80(2):161-6. PubMed ID: 1972670 [Abstract] [Full Text] [Related]
39. Comparison among delayed-type skin tests, serum IgE levels and peripheral blood CD4 in HIV-positive patients. Alonso A, Coduri CL, Bignone ML, Pionetti CH. J Investig Allergol Clin Immunol; 1997 May 23; 7(3):183-5. PubMed ID: 9252878 [Abstract] [Full Text] [Related]